The Institute of Cancer Research, London, Selects Vortex from Dotmatics to Assist with the Discovery of New Cancer Drugs

The Institute of Cancer Research, London, Selects Vortex from Dotmatics to Assist with the Discovery of New Cancer Drugs

BISHOPS STORTFORD, England, Sep 20, 2012  -- Dotmatics Limited, a leading provider of scientific informatics solutions and services to the pharmaceutical and biotechnology industries, announces that one of the world's most influential cancer research institutes, The Institute of Cancer Research, London, has deployed its premium data visualisation and analysis tool Vortex, to help in the quest to discover and develop new cancer drugs.

Dotmatics' Vortex is a world-class visualisation and analytics platform designed specifically for analysis and interrogation of scientific data. Vortex provides users with an out-of the-box filtering, charting, plotting and chemically aware calculations engine, enabling scientists to evaluate large datasets in a rich, intuitive and flexible user interface. The use of Vortex helps uncover hidden data trends and correlations and identify new potential drug candidates.

After rigorous internal testing, The Institute of Cancer Research (ICR) selected Dotmatics' Vortex because of its "flexibility, ease of use and swift integration with our existing chemoinformatics data storage platform," said Professor Julian Blagg, Head of Chemistry and Deputy Director of the Division of Cancer Therapeutics at The Institute of Cancer Research. "It allows the visualisation of multidimensional datasets on compounds of interest to study trends, relationships and to discover outliers," he added.

"We are delighted that such a prestigious cancer research organisation has chosen Dotmatics as their informatics supplier," said Dr. Stephen Gallagher, CEO of Dotmatics. "We invest heavily in Vortex to guarantee that it continues to be the best data analysis and visualisation tool for scientists across the world. We will continue to work with the ICR to ensure the development of our solutions matches their ever changing needs" he added.

About Dotmatics

Dotmatics has rapidly emerged as a preferred informatics supplier to many of the world's largest global Pharmaceutical, Biotechnology and Academic organisations. Dotmatics is a scientific software company deploying web-based knowledge solutions that dramatically improve the way scientific data is queried, managed and shared within companies. Dotmatics has significant expertise in Cheminformatics and Bioinformatics techniques including Chemical databases, SAR analysis, data management and data visualisation. A privately owned company, Dotmatics was founded in 2005 and has its head office based south of Cambridge, UK.

About The Institute of Cancer Research

The Institute of Cancer Research (ICR) is one of the world's most influential cancer research institutes.

Scientists and clinicians at the ICR are working every day to make a real impact on cancer patients' lives. Through its unique partnership with The Royal Marsden Hospital and 'bench-to-bedside' approach, the ICR is able to create and deliver results in a way that other institutions cannot. Together the two organisations are rated in the top four cancer centres globally.

The ICR has an outstanding record of achievement dating back more than 100 years. It provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today it leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

As a college of the University of London, the ICR provides postgraduate higher education of international distinction. It has charitable status and relies on support from partner organisations, charities and the general public.

The ICR's mission is to make the discoveries that defeat cancer. For more information visit www.icr.ac.uk

SOURCE: Dotmatics Limited

       
        Enquiries:
        Dotmatics Limited
        Dr. Mariana Vaschetto
        Tel (Europe): +44(0)1279 654 123
        Tel (US West Coast): +1 (619) 419 2808
        Tel (US East Coast): +1 (781) 281 2330
        Email: [email protected]

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.